Immunotherapy in ovarian cancer
Author:
Funder
National Cancer Institute
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/28/suppl_8/viii1/24169566/mdx444.pdf
Reference53 articles.
1. Global estimates of cancer prevalence for 27 sites in the adult population in 2008;Bray;Int J Cancer,2013
2. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012;Ferlay;Eur Cancer,2013
3. Cancer statistics, 2013;Siegel;Ca Cancer J Clin,2013
4. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer;Sato;Proc Natl Acad Sci USA,2005
5. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer;Zhang;N Engl J Med,2003
Cited by 290 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A novel selective FAK inhibitor E2 inhibits ovarian cancer metastasis and growth by inducing cytotoxic autophagy;Biochemical Pharmacology;2024-11
2. Biomimetic nanomedicine cocktail enables selective cell targeting to enhance ovarian Cancer chemo- and immunotherapy;Journal of Controlled Release;2024-09
3. Advances and challenges in the origin and evolution of ovarian cancer organoids;Frontiers in Oncology;2024-08-16
4. The role of mitochondrial genes in the prognosis of ovarian cancer: new insights from bioinformatics;2024-08-11
5. CAR-T therapy for ovarian cancer: Recent advances and future directions;Biochemical Pharmacology;2024-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3